Thought I would post the trofinetide paediatric Rett P2 efficacy results as a point of reference. One thing to note is the effective dose (200 mg/kg) arm had n=27 where we have n=20 in the PMS trial so statistical significance will be a point of interest. This is also placebo-controlled and blinded whereas PMS is open label using baseline as a control.
Share Price, page-8271
-
- There are more pages in this discussion • 3,017 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.61 |
Change
0.010(0.06%) |
Mkt cap ! $1.995B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.44 | $8.412M | 538.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 558 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 1841 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |